ArticleAmerican journal of ophthalmology case reports2025
Serous retinal detachment secondary to bilateral choroidal osteoma successfully treated with subscleral sclerectomy: A case report.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Development of Choroidal Osteoma in an Eye with Punctate Inner Choroidopathy: A Case Report and Review of Literature.International medical case reports journal · 2026Article
- Choroidal Osteoma with Focal Choroidal Excavation Masquerading as Active Vogt-Koyanagi-Harada: A Case Report.Case reports in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report a case of bilateral choroidal osteoma successfully treated with subscleral sclerectomy for secondary serous retinal detachment (SRD). Observations: A 52-year-old Japanese woman first diagnosed with Vogt-Koyanagi-Harada disease and treated with steroids for 9 years was referred to our clinic. SRD in both eyes recurred frequently and was uncontrolled with adalimumab subcutaneous injections and oral cyclosporine, in addition to steroids. A yellowish-to-orange, slightly elevated subretinal lesion was observed superior to the macular and inferotemporal regions of the right eye and superior to the macular and temporal regions of the left eye without any inflammation. Swept-source optical coherence tomography (OCT) revealed SRD in the fovea and a mass under the retinal pigment epithelium (RPE) in the macular area of both eyes. Indocyanine green angiography (ICGA) demonstrated hypocyanescence corresponding to the mass area under the RPE, with dilation of the dominant vortex veins. Ultrasonography revealed a hyperechogenic mass in the posterior wall of both eyes with deeper acoustic shadows, and computed tomography (CT) detected calcifications in the posterior wall of both eyes. A bilateral choroidal osteoma was diagnosed, and the superior SRD of her left eye increased toward the fovea without any evidence of choroidal neovascularization during follow-up. Therefore, subscleral sclerectomy (4 × 4 mm Conclusions and Importance: Choroidal osteoma can cause severe SRD that cannot be controlled with medication. Although further studies are needed, subscleral sclerectomy may be an effective treatment for the resolution of subretinal fluid secondary to choroidal osteoma by improving choroidal circulation congestion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.